EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Targeting Neuronal Nicotinic Receptors: a Path to New Therapies

Merouane Bencherif, Jeffrey D Schmitt

Current Drug Target -CNS & Neurological Disorders · 2002

DOI: 10.2174/1568007023339094 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Drug Target -CNS & Neurological Disorders, 2002. Verfasst von Merouane Bencherif und 1 weiteren Autor:innen. Beteiligte Einrichtung: Targacept Inc., 200 East First Street, Suite 300, Winston-Salem, NC 27101-4165, USA. merouane.bencherif@targacept.com. Die Arbeit wurde bisher 27-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The structural heterogeneity, the ubiquity of anatomical distribution, and the demonstrated modulation of biological functions is consistent with the view that nicotinic cholinergic signaling plays a key regulatory role in the brain and influences a number of neuronal processes including sensory processing, motor activity, and cognitive function. It has become evident that perturbation of nicotinic cholinergic neurotransmission can result in diverse CNS pathologies providing the potential for therapeutic intervention in a number of neurodegenerative, neuropsychiatric and neurological disorders. This review will provide a status on the rationale for neuronal therapies targeting neuronal nicotinic receptors (nAChRs) and discusses the multifaceted beneficial effects than can be achieved through manipulation of cholinergic pharmacology. Recent advances and issues relating to rational drug design based on the structure of acetylcholine binding protein are discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsDrug DesignHumansMental DisordersNervous System DiseasesNeuronsNeuroprotective AgentsNicotinic AgonistsNicotinic AntagonistsReceptors, Nicotinic

Substanzen

Neuroprotective AgentsNicotinic AgonistsNicotinic AntagonistsReceptors, Nicotinic

Autor:innen und Institutionen

  • Targacept Inc., 200 East First Street, Suite 300, Winston-Salem, NC 27101-4165, USA. merouane.bencherif@targacept.com

Zitieren

APA

Bencherif, M., & Schmitt, J. D. (2002). Targeting Neuronal Nicotinic Receptors: a Path to New Therapies. Current Drug Target -CNS & Neurological Disorders. https://doi.org/10.2174/1568007023339094

Vancouver

Bencherif M, Schmitt JD. Targeting Neuronal Nicotinic Receptors: a Path to New Therapies. Current Drug Target -CNS & Neurological Disorders. 2002. doi:10.2174/1568007023339094

BibTeX
@article{Bencherif2002,
  author = {Bencherif, Merouane and Schmitt, Jeffrey D},
  title = {Targeting Neuronal Nicotinic Receptors: a Path to New Therapies},
  journal = {Current Drug Target -CNS & Neurological Disorders},
  year = {2002},
  doi = {10.2174/1568007023339094}
}
Kostenlos starten →